Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression

Cardiac dysfunction is a major consequence of sepsis/septic shock and contributes to the high mortality of sepsis. Innate and inflammatory responses mediated by TLRs play a critical role in sepsis-induced cardiac dysfunction. MicroRNA-146 (miR-146) was first identified as a negative regulator in innate immune and inflammatory responses induced by LPS. This study examined whether miR-146a will have a protective effect on sepsis-induced cardiac dysfunction. Lentivirus-expressing miR-146a (LmiR-146a) or lentivirus-expressing scrambled miR (LmiR-control) was delivered into the myocardium via the right carotid artery. Seven days after transfection, mice were subjected to cecal ligation and puncture (CLP). Untransfected mice were also subjected to CLP-induced sepsis. Cardiac function was examined by echocardiography before and 6 h after CLP. In vitro studies showed that increased miR-146a levels suppress LPS-induced IκBα phosphorylation and inflammatory cytokine production in both H9C2 cardiomyocytes and J774 macrophages. In vivo transfection of LmiR-146a attenuated sepsis-induced cardiac dysfunction. The values for percent ejection fraction and percent fractional shortening in LmiR-146a–transfected CLP mice were significantly greater than in untransfected CLP control. LmiR-146a transfection prevented sepsis-induced NF-κB activity, suppressed IRAK and TRAF6 expression in the myocardium, and attenuated sepsis-induced inflammatory cytokine production in both plasma and peritoneal fluid. In addition, LmiR-146a transfection decreased sepsis-induced infiltration of neutrophils and macrophages into the myocardium. LmiR-146a can also transfect macrophages in the periphery. We conclude that miR-146a attenuates sepsis-induced cardiac dysfunction by preventing NF-κB activation, inflammatory cell infiltration, and inflammatory cytokine production via targeting of IRAK and TRAF6 in both cardiomyocytes and inflammatory monocytic cells.

[1]  J. Kalbfleisch,et al.  MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. , 2014, Cardiovascular research.

[2]  D. Angus,et al.  Epidemiology of severe sepsis , 2013, Virulence.

[3]  J. Kalbfleisch,et al.  The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling. , 2013, The Journal of infectious diseases.

[4]  J. Kalbfleisch,et al.  Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. , 2013, Cardiovascular research.

[5]  J. Andersson,et al.  Circulating Monocytes Are Not the Major Source of Plasma Cytokines in Patients With Sepsis , 2012, Shock.

[6]  L. Kobzik,et al.  MicroRNA-181b regulates NF-κB-mediated vascular inflammation. , 2012, The Journal of clinical investigation.

[7]  C. J. Fernandes Jr.,et al.  Myocardial Dysfunction in Sepsis: A Large, Unsolved Puzzle , 2012, Critical care research and practice.

[8]  Zhijian J. Chen,et al.  Ubiquitination in signaling to and activation of IKK , 2012, Immunological reviews.

[9]  C. McCall,et al.  MicroRNA‐146a regulates both transcription silencing and translation disruption of TNF‐α during TLR4‐induced gene reprogramming , 2011, Journal of leukocyte biology.

[10]  Yan Li,et al.  MyD88 and Trif Signaling Play Distinct Roles in Cardiac Dysfunction and Mortality during Endotoxin Shock and Polymicrobial Sepsis , 2011, Anesthesiology.

[11]  E. Porat,et al.  Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility. , 2011, Antioxidants & redox signaling.

[12]  E. Chan,et al.  MicroRNA in TLR signaling and endotoxin tolerance , 2011, Cellular and Molecular Immunology.

[13]  Susan R. Quinn,et al.  A trio of microRNAs that control Toll-like receptor signalling. , 2011, International immunology.

[14]  Ryan M. O’Connell,et al.  NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies , 2011, Proceedings of the National Academy of Sciences.

[15]  L. O’Neill,et al.  MicroRNAs: the fine-tuners of Toll-like receptor signalling , 2011, Nature Reviews Immunology.

[16]  Luca Sterpone,et al.  Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs , 2010, PloS one.

[17]  David L. Williams,et al.  Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis* , 2010, Critical care medicine.

[18]  M. Scherrer-Crosbie,et al.  Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis* , 2010, Critical care medicine.

[19]  Xi-sha Chen,et al.  MicroRNA‐146a and Human Disease , 2010, Scandinavian journal of immunology.

[20]  J. Kalbfleisch,et al.  TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. , 2010, American journal of physiology. Heart and circulatory physiology.

[21]  Ryan M. O’Connell,et al.  Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.

[22]  T. Ha,et al.  The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury. , 2009, Cardiovascular research.

[23]  B. Schroen,et al.  MicroRNAs and beyond: the heart reveals its treasures. , 2009, Hypertension.

[24]  L. O’Neill,et al.  Adding fuel to fire: microRNAs as a new class of mediators of inflammation , 2008, Annals of the rheumatic diseases.

[25]  E. Olson,et al.  Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.

[26]  F. Cunha,et al.  THE ROLE OF NEUTROPHILS IN SEVERE SEPSIS , 2008, Shock.

[27]  Peter A. Ward,et al.  Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.

[28]  A. Pivarcsi,et al.  MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. , 2008, Seminars in cancer biology.

[29]  Meijing Wang,et al.  INTERLEUKIN 18 IN THE HEART , 2007, Shock.

[30]  David L. Williams,et al.  Protection against Myocardial Ischemia/Reperfusion Injury in TLR4-Deficient Mice Is Mediated through a Phosphoinositide 3-Kinase-Dependent Mechanism1 , 2007, The Journal of Immunology.

[31]  D. Baltimore,et al.  MicroRNAs and immunity: tiny players in a big field. , 2007, Immunity.

[32]  J. Kalbfleisch,et al.  Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice. , 2006, American journal of physiology. Heart and circulatory physiology.

[33]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[34]  J. Cavaillon,et al.  Monocytes/macrophages and sepsis. , 2005, Critical care medicine.

[35]  J. Kalbfleisch,et al.  Modulation of the Phosphoinositide 3-Kinase Pathway Alters Innate Resistance to Polymicrobial Sepsis 1 , 2004, The Journal of Immunology.

[36]  D. Kusewitt,et al.  IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction. , 2003, American journal of physiology. Heart and circulatory physiology.

[37]  J. Kalbfleisch,et al.  Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. , 2003, Critical care medicine.

[38]  A. Harken,et al.  ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[39]  J. Kalbfleisch,et al.  Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3)-β-D -glucan increases long-term survival in polymicrobial sepsis , 1999 .

[40]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[41]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.

[42]  S. Ghosh,et al.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. , 2001, The Journal of clinical investigation.